Tawbi H - Search Results

1

Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.

Kirkwood JM, Kottschade LA, McWilliams RR, Khushalani NI, Jang S, Hallmeyer S, McDermott DF, Tawbi H, Che M, Lee CH, Ritchings C, Le TK, Park B, Ramsey S. Kirkwood JM, et al. Among authors: tawbi h. Immunotherapy. 2024 Jan;16(1):29-42. doi: 10.2217/imt-2022-0292. Epub 2023 Nov 8. Immunotherapy. 2024. PMID: 37937397 Free article.

2

Management of metastatic melanoma.

Tawbi HA, Kirkwood JM. Tawbi HA, et al. Semin Oncol. 2007 Dec;34(6):532-45. doi: 10.1053/j.seminoncol.2007.09.008. Semin Oncol. 2007. PMID: 18083377 Review.

3

Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?

Kirkwood JM, Tawbi HA, Tarhini AA, Moschos SJ. Kirkwood JM, et al. Nat Clin Pract Oncol. 2009 Feb;6(2):70-1. doi: 10.1038/ncponc1297. Epub 2008 Dec 17. Nat Clin Pract Oncol. 2009. PMID: 19092800

4

Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours.

Tawbi HA, Villaruz L, Tarhini A, Moschos S, Sulecki M, Viverette F, Shipe-Spotloe J, Radkowski R, Kirkwood JM. Tawbi HA, et al. Br J Cancer. 2011 Sep 6;105(6):773-7. doi: 10.1038/bjc.2011.285. Epub 2011 Aug 2. Br J Cancer. 2011. PMID: 21811257 Free PMC article. Clinical Trial.

5

Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma.

Tarhini AA, Cherian J, Moschos SJ, Tawbi HA, Shuai Y, Gooding WE, Sander C, Kirkwood JM. Tarhini AA, et al. J Clin Oncol. 2012 Jan 20;30(3):322-8. doi: 10.1200/JCO.2011.37.5394. Epub 2011 Dec 19. J Clin Oncol. 2012. PMID: 22184371 Free PMC article. Clinical Trial.

6

Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect.

Tawbi HA, Kirkwood JM. Tawbi HA, et al. Nat Rev Clin Oncol. 2012 Sep;9(9):496-7. doi: 10.1038/nrclinonc.2012.138. Epub 2012 Aug 14. Nat Rev Clin Oncol. 2012. PMID: 22889973 No abstract available.

7

Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis.

Tawbi HA, Beumer JH, Tarhini AA, Moschos S, Buch SC, Egorin MJ, Lin Y, Christner S, Kirkwood JM. Tawbi HA, et al. Ann Oncol. 2013 Apr;24(4):1112-9. doi: 10.1093/annonc/mds591. Epub 2012 Nov 21. Ann Oncol. 2013. PMID: 23172636 Free PMC article. Clinical Trial.

8

Melanoma brain metastases: an unmet challenge in the era of active therapy.

Gorantla V, Kirkwood JM, Tawbi HA. Gorantla V, et al. Curr Oncol Rep. 2013 Oct;15(5):483-91. doi: 10.1007/s11912-013-0335-3. Curr Oncol Rep. 2013. PMID: 23954973 Free PMC article. Review.

9

MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603.

Villaruz LC, Huang G, Romkes M, Kirkwood JM, Buch SC, Nukui T, Flaherty KT, Lee SJ, Wilson MA, Nathanson KL, Benos PV, Tawbi HA. Villaruz LC, et al. Clin Epigenetics. 2015 Jun 4;7(1):58. doi: 10.1186/s13148-015-0092-2. eCollection 2015. Clin Epigenetics. 2015. PMID: 26052356 Free PMC article.

10

High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute.

Davar D, Ding F, Saul M, Sander C, Tarhini AA, Kirkwood JM, Tawbi HA. Davar D, et al. J Immunother Cancer. 2017 Sep 19;5(1):74. doi: 10.1186/s40425-017-0279-5. J Immunother Cancer. 2017. PMID: 28923120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters